Tag: chronic conditions

The Endocrine Society, the world’s oldest and largest organization devoted to hormone research and the clinical practice of endocrinology, has officially announced the selection of five distinguished scientists as the recipients of its 2026 Early Investigator Awards. This prestigious recognition is designed to bolster the professional trajectories of scientists in the formative years of their…

A landmark study published in The Journal of Clinical Endocrinology & Metabolism (JCEM) has provided definitive evidence identifying obesity and high blood pressure as direct causal drivers of vascular-related dementia. The research, titled High Body Mass Index as a Causal Risk Factor for Vascular-Related Dementia: A Mendelian Randomization Study, offers a significant breakthrough in understanding…

The international medical community is mourning the death of Martin O. Savage, Emeritus Professor of Pediatric Endocrinology at the William Harvey Research Institute, Barts and The London School of Medicine & Dentistry, Queen Mary University of London. Professor Savage, a figure of immense influence in the field of pediatrics and endocrinology, died on February 24,…

The Endocrine Society has officially announced its endorsement of the Improving Needed Safeguards for Users of Lifesaving Insulin Now (INSULIN) Act, a landmark piece of bipartisan legislation designed to fundamentally alter the pricing landscape of insulin in the United States. Introduced by a coalition of senators including Jeanne Shaheen (D-NH), Susan Collins (R-ME), Raphael Warnock…

The clinical landscape of obesity management is undergoing a significant paradigm shift, moving away from a purely metrics-driven approach toward a more nuanced, patient-centric model. Dr. Zeb I. Saeed, an adult endocrinologist at Brigham and Women’s Hospital and a member of the steering committee for the Endocrine Society’s Early Career Special Interest Group (SIG), has…

The landscape of endocrine medicine underwent a significant transformation this month as the U.S. Food and Drug Administration (FDA) issued a landmark approval for the first once-weekly basal insulin, while a sophisticated new artificial intelligence platform launched to tackle the diagnostic complexities of chronic metabolic disease. Simultaneously, progress in the rare disease sector continues as…

The global medical community is witnessing a transformative shift in the approach to the obesity epidemic, transitioning from a historical focus on behavioral modification to a sophisticated, multi-faceted medical strategy. While the prevalence of overweight and obesity remains a critical public health challenge worldwide, recent breakthroughs in pharmacology and a deeper understanding of metabolic science…

The Endocrine Society has announced a comprehensive expansion of its professional development portfolio, signaling a robust commitment to addressing the evolving needs of the global endocrine workforce. As the medical community faces a projected shortage of specialists alongside a rising prevalence of endocrine-related chronic conditions such as diabetes, obesity, and thyroid disorders, the Society’s strategic…

The global medical community is currently engaged in a rigorous debate over the fundamental definition of obesity, a discussion that carries significant implications for millions of patients and the healthcare systems that serve them. At the center of this controversy is a recent critique published in The Journal of Clinical Endocrinology & Metabolism by the…

In a landmark week for the pharmaceutical industry, the U.S. Food and Drug Administration (FDA) has granted approval for a new oral obesity medication, while clinical advancements in the treatment of rare endocrine disorders have signaled a potential shift in the standard of care for patients with Thyroid Eye Disease (TED). These developments, led by…